Updates are available Correction dated 2025-10-06
Click to view Correction: https://doi.org/10.1007/s00270-025-04233-1
-
Authors
Bilhim, Tiago https://orcid.org/0000-0003-3044-8474
- License Information
-
More Information
Article History
Received: 13 July 2025
Accepted: 12 September 2025
First Online: 25 September 2025
Declarations
:
: Tiago Bilhim has received speaker fees for Philips Medical, Cook Medical, Terumo, Merit Medical, Guerbet and is a stockholder for EmbolX.
: Institutional review board approval, consent for publication, and informed consent were not needed for this Editorial.
Free to read: This content has been made available to all.
